Published in J Invest Dermatol on September 28, 2006
The astrocyte odyssey. Prog Neurobiol (2008) 2.58
Genetic ablation of alphav integrins in epithelial cells of the eyelid skin and conjunctiva leads to squamous cell carcinoma. Am J Pathol (2008) 0.92
Evolutionary etiology of high-grade astrocytomas. Proc Natl Acad Sci U S A (2013) 0.89
Epithelial-mesenchymal transition, and collective and individual cell migration regulate epithelial changes in the amikacin-damaged organ of Corti. Histochem Cell Biol (2017) 0.80
Keratinocytes as depository of ammonium-inducible glutamine synthetase: age- and anatomy-dependent distribution in human and rat skin. PLoS One (2009) 0.79
Astrocytes reassessment - an evolving concept part one: embryology, biology, morphology and reactivity. J Mol Psychiatry (2013) 0.78
Hepatic autophagy is differentially regulated in periportal and pericentral zones - a general mechanism relevant for other tissues? Cell Commun Signal (2013) 0.78
Circulating tumor cell is a common property of brain glioma and promotes the monitoring system. Oncotarget (2016) 0.77
Evidence for nuclear interaction of a cytoskeleton protein (OsIFL) with metallothionein and its role in salinity stress tolerance. Sci Rep (2016) 0.75
Expandable and Rapidly Differentiating Human Induced Neural Stem Cell Lines for Multiple Tissue Engineering Applications. Stem Cell Reports (2016) 0.75
Spontaneous Development of Cutaneous Squamous Cell Carcinoma in Mice with Cell-specific Deletion of Inhibitor of κB Kinase 2. Comp Med (2017) 0.75
Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME. Arch Toxicol (2013) 3.00
Using trade names: a risk factor for accidental drug overdose. Arch Intern Med (2002) 2.91
Prediction and validation of cell alignment along microvessels as order principle to restore tissue architecture in liver regeneration. Proc Natl Acad Sci U S A (2010) 2.50
Influence of willow bark extract on cyclooxygenase activity and on tumor necrosis factor alpha or interleukin 1 beta release in vitro and ex vivo. Clin Pharmacol Ther (2003) 2.08
Hepatocyte-specific Smad7 expression attenuates TGF-beta-mediated fibrogenesis and protects against liver damage. Gastroenterology (2008) 2.07
Tubular overexpression of transforming growth factor-beta1 induces autophagy and fibrosis but not mesenchymal transition of renal epithelial cells. Am J Pathol (2010) 1.93
Integrated metabolic spatial-temporal model for the prediction of ammonia detoxification during liver damage and regeneration. Hepatology (2014) 1.93
Off label prescribing to children in primary care in Germany: retrospective cohort study. BMJ (2002) 1.88
Modulation of glutamine metabolism by the PI(3)K-PKB-FOXO network regulates autophagy. Nat Cell Biol (2012) 1.63
Ezetimibe and statin-associated myopathy. Ann Intern Med (2004) 1.58
Conditional tetracycline-regulated expression of TGF-beta1 in liver of transgenic mice leads to reversible intermediary fibrosis. Hepatology (2003) 1.48
Hepatic expression of glutamine synthetase in rats is controlled by STAT5 and TCF transcription factors. Hepatology (2006) 1.47
Multilineage differentiation potential of human dermal skin-derived fibroblasts. Exp Dermatol (2008) 1.44
Pharmacokinetic study of artemisinin after oral intake of a traditional preparation of Artemisia annua L. (annual wormwood). Am J Trop Med Hyg (2004) 1.43
Mathematical modelling of liver regeneration after intoxication with CCl(4). Chem Biol Interact (2007) 1.35
Synthesis and biological evaluation of new derivatives of emodin. Bioorg Med Chem (2004) 1.30
Transcription factors ETF, E2F, and SP-1 are involved in cytokine-independent proliferation of murine hepatocytes. Hepatology (2010) 1.25
Therapeutic efficacy of intranasally delivered mesenchymal stem cells in a rat model of Parkinson disease. Rejuvenation Res (2011) 1.21
Overexpression of glutamine synthetase is associated with beta-catenin-mutations in mouse liver tumors during promotion of hepatocarcinogenesis by phenobarbital. Cancer Res (2002) 1.19
Profibrogenic transforming growth factor-beta/activin receptor-like kinase 5 signaling via connective tissue growth factor expression in hepatocytes. Hepatology (2007) 1.19
Protective effects of intranasal losartan in the APP/PS1 transgenic mouse model of Alzheimer disease. Rejuvenation Res (2010) 1.19
Intranasal delivery of cells to the brain. Eur J Cell Biol (2009) 1.18
Safety and enhanced immunogenicity of a hepatitis B core particle Plasmodium falciparum malaria vaccine formulated in adjuvant Montanide ISA 720 in a phase I trial. Infect Immun (2005) 1.17
Pharmacogenetics of antimalarial drugs: effect on metabolism and transport. Lancet Infect Dis (2009) 1.16
Functional interactions of Cu-ATPase ATP7B with cisplatin and the role of ATP7B in the resistance of cells to the drug. J Biol Chem (2009) 1.12
Curcumin inhibits glyoxalase 1: a possible link to its anti-inflammatory and anti-tumor activity. PLoS One (2008) 1.11
Protocols for staining of bile canalicular and sinusoidal networks of human, mouse and pig livers, three-dimensional reconstruction and quantification of tissue microarchitecture by image processing and analysis. Arch Toxicol (2014) 1.10
Correlation between beta-catenin mutations and expression of Wnt-signaling target genes in hepatocellular carcinoma. Mol Cancer (2008) 1.10
Carnosine inhibits ATP production in cells from malignant glioma. Neurol Res (2009) 1.09
High circulating leptin receptors with normal leptin sensitivity in liver-specific insulin receptor knock-out (LIRKO) mice. J Biol Chem (2007) 1.09
Investigation of the membrane localization and distribution of flavonoids by high-resolution magic angle spinning NMR spectroscopy. Biochim Biophys Acta (2004) 1.06
Cyclooxygenase-2 expression in human colorectal cancer is unrelated to overall patient survival. Clin Cancer Res (2005) 1.05
The virtual liver: state of the art and future perspectives. Arch Toxicol (2014) 1.05
Dose-proportional intraindividual single- and repeated-dose pharmacokinetics of roflumilast, an oral, once-daily phosphodiesterase 4 inhibitor. J Clin Pharmacol (2007) 1.02
Pharmacokinetic modelling of morphine, morphine-3-glucuronide and morphine-6-glucuronide in plasma and cerebrospinal fluid of neurosurgical patients after short-term infusion of morphine. Br J Clin Pharmacol (2002) 1.00
"Artificial micro organs"--a microfluidic device for dielectrophoretic assembly of liver sinusoids. Biomed Microdevices (2011) 0.99
Carnosine retards tumor growth in vivo in an NIH3T3-HER2/neu mouse model. Mol Cancer (2010) 0.97
Prediction of breast cancer by profiling of urinary RNA metabolites using Support Vector Machine-based feature selection. BMC Cancer (2009) 0.96
Functional endogenous LINE-1 retrotransposons are expressed and mobilized in rat chloroleukemia cells. Nucleic Acids Res (2007) 0.95
Glucocorticoid induced expression of glutamine synthetase in hepatoma cells. Biochem Biophys Res Commun (2002) 0.94
Cytoplasmic intermediate filaments are stably associated with nuclear matrices and potentially modulate their DNA-binding function. DNA Cell Biol (2002) 0.94
Inducible neuronal expression of transgenic TGF-beta1 in vivo: dissection of short-term and long-term effects. Eur J Neurosci (2005) 0.94
Lack of effect of extracellular adenosine generation and signaling on renal erythropoietin secretion during hypoxia. Am J Physiol Renal Physiol (2007) 0.94
Metabonomics in cancer diagnosis: mass spectrometry-based profiling of urinary nucleosides from breast cancer patients. Biomarkers (2008) 0.93
Impact of CYP2D6 genotype on adverse effects during treatment with metoprolol: a prospective clinical study. Clin Pharmacol Ther (2005) 0.93
A systematic evaluation of the use of physiologically based pharmacokinetic modeling for cross-species extrapolation. J Pharm Sci (2014) 0.93
Protective effects of flavonoids and two metabolites against oxidative stress in neuronal PC12 cells. Life Sci (2009) 0.93
Inhibition of matrix metalloproteinase-2 and -9 activities by selected flavonoids. Planta Med (2004) 0.92
Alpha2-macroglobulin inhibits the malignant properties of astrocytoma cells by impeding beta-catenin signaling. Cancer Res (2010) 0.91
Novel regulatory mechanisms for generation of the soluble leptin receptor: implications for leptin action. PLoS One (2012) 0.91
Pharmacokinetics of natural mistletoe lectins after subcutaneous injection. Eur J Clin Pharmacol (2010) 0.90
Metabolic signature of breast cancer cell line MCF-7: profiling of modified nucleosides via LC-IT MS coupling. BMC Biochem (2007) 0.90
Aldosterone and D-glucose stimulate the proliferation of human cardiac myofibroblasts in vitro. Hypertension (2002) 0.90
Mass spectrometric identification of modified urinary nucleosides used as potential biomedical markers by LC-ITMS coupling. Anal Bioanal Chem (2005) 0.89
A silencer element in the first intron of the glutamine synthetase gene represses induction by glucocorticoids. Mol Endocrinol (2003) 0.89
Protective effects of ellagic and chlorogenic acids against oxidative stress in PC12 cells. Free Radic Res (2005) 0.88
Bioinformatical evaluation of modified nucleosides as biomedical markers in diagnosis of breast cancer. Anal Chim Acta (2008) 0.88
Type III intermediate filament proteins interact with four-way junction DNA and facilitate its cleavage by the junction-resolving enzyme T7 endonuclease I. DNA Cell Biol (2003) 0.87
Selectin binding is essential for peritoneal carcinomatosis in a xenograft model of human pancreatic adenocarcinoma in pfp--/rag2-- mice. Gut (2012) 0.87
Interaction in vitro of type III intermediate filament proteins with higher order structures of single-stranded DNA, particularly with G-quadruplex DNA. DNA Cell Biol (2005) 0.86
Organization of focal adhesion plaques is disrupted by action of the HIV-1 protease. Cell Biol Int (2002) 0.86
Glial fibrillary acidic protein-positive cells of the kidney are capable of raising a protective biochemical barrier similar to astrocytes: expression of metallothionein in podocytes. Anat Rec (2002) 0.86
Identification of factors involved in the anti-tumor activity of carnosine on glioblastomas using a proteomics approach. Cancer Invest (2011) 0.86
Affinities of dihydrocodeine and its metabolites to opioid receptors. Pharmacol Toxicol (2002) 0.85
HPLC-MS/MS analysis of willow bark extracts contained in pharmaceutical preparations. Phytochem Anal (2005) 0.85
Hedgehog signaling in glioblastoma multiforme. Cancer Biol Ther (2012) 0.85
MALDI-TOF MS analysis of urinary nucleosides. J Am Soc Mass Spectrom (2005) 0.84
Tissue proteomics by one-dimensional gel electrophoresis combined with label-free protein quantification. J Proteome Res (2012) 0.84
[Quality of antithrombotic therapy in patients with chronic atrial fibrillation: the AFib Trial]. Z Arztl Fortbild Qualitatssich (2003) 0.84
Serum IGF-I is not a reliable pharmacodynamic marker of exogenous growth hormone activity in mice. Endocrinology (2011) 0.84
Response of sinusoidal mouse liver cells to choline-deficient ethionine-supplemented diet. Comp Hepatol (2010) 0.84
The extended TILAR approach: a novel tool for dynamic modeling of the transcription factor network regulating the adaption to in vitro cultivation of murine hepatocytes. BMC Syst Biol (2012) 0.84
An intronic silencer element is responsible for specific zonal expression of glutamine synthetase in the rat liver. Hepatology (2005) 0.83
Spontaneously immortalized mouse embryo fibroblasts: growth behavior of wild-type and vimentin-deficient cells in relation to mitochondrial structure and activity. DNA Cell Biol (2005) 0.83
Reduction and expansion of the glutamine synthetase expressing zone in livers from tetracycline controlled TGF-beta1 transgenic mice and multiple starved mice. J Hepatol (2004) 0.83
Antioxidant properties of silybin glycosides. Phytother Res (2002) 0.83
Determination of fenoterol in human plasma by HPLC with fluorescence detection after derivatization. J Pharm Biomed Anal (2002) 0.82
Intranasal delivery of bone marrow-derived mesenchymal stem cells, macrophages, and microglia to the brain in mouse models of Alzheimer's and Parkinson's disease. Cell Transplant (2014) 0.82
Differential inhibition of matrix metalloproteinases-2, -9, and -13 activities by selected anthraquinones. Planta Med (2009) 0.82
E-cadherin as a reliable cell surface marker for the identification of liver specific stem cells. J Mol Histol (2007) 0.82
Effects of CYP2C9 polymorphisms on the pharmacokinetics of R- and S-phenprocoumon in healthy volunteers. Pharmacogenetics (2004) 0.81
Pharmacokinetics of ML3403 ({4-[5-(4-fluorophenyl)-2-methylsulfanyl-3H-imidazol-4-yl]-pyridin-2-yl}-(1-phenylethyl)-amine), a 4-Pyridinylimidazole-type p38 mitogen-activated protein kinase inhibitor. Drug Metab Dispos (2007) 0.81
Quantitative determination of piritramide in human plasma and urine by off- and on-line solid-phase extraction liquid chromatography coupled to tandem mass spectrometry. Rapid Commun Mass Spectrom (2006) 0.81
The RL-ET-14 cell line mediates expression of glutamine synthetase through the upstream enhancer/promoter region. J Hepatol (2005) 0.81
Interaction in vitro of type III intermediate filament proteins with triplex DNA. DNA Cell Biol (2002) 0.81
The targeted oral, once-daily phosphodiesterase 4 inhibitor roflumilast and the leukotriene receptor antagonist montelukast do not exhibit significant pharmacokinetic interactions. J Clin Pharmacol (2009) 0.81
Deletion mutagenesis of the amino-terminal head domain of vimentin reveals dispensability of large internal regions for intermediate filament assembly and stability. Exp Cell Res (2002) 0.81
Comparative in vitro toxicity of seven zinc-salts towards neuronal PC12 cells. Toxicol In Vitro (2009) 0.80
Heterogeneous expression of suppressor of cytokine signalling 2 (SOCS-2) in liver tissue. J Anat (2009) 0.80
Theophylline improves early allograft function in rat kidney transplantation. J Pharmacol Exp Ther (2006) 0.80
Flavonoid binding to a multi-drug-resistance transporter protein: an STD-NMR study. Anal Bioanal Chem (2004) 0.80
Identification of urinary modified nucleosides and ribosylated metabolites in humans via combined ESI-FTICR MS and ESI-IT MS analysis. J Am Soc Mass Spectrom (2008) 0.80
Ginger-associated overanticoagulation by phenprocoumon. Ann Pharmacother (2003) 0.79
From teratogens to potential therapeutics: natural inhibitors of the Hedgehog signaling network come of age. Planta Med (2009) 0.79
Angiotensin receptor type 1 blockade in astroglia decreases hypoxia-induced cell damage and TNF alpha release. Neurochem Res (2007) 0.79
Effect of high-dose metronidazole on pharmacokinetics of oral budesonide and vice versa: a double drug interaction study. J Clin Pharmacol (2007) 0.79
Keratinocytes as depository of ammonium-inducible glutamine synthetase: age- and anatomy-dependent distribution in human and rat skin. PLoS One (2009) 0.79